Stoke Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stoke therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stoke Therapeutic Today - Breaking & Trending Today

HC Wainwright Brokers Cut Earnings Estimates for Stoke Therapeutics, Inc. (NASDAQ:STOK)

HC Wainwright Brokers Cut Earnings Estimates for Stoke Therapeutics, Inc. (NASDAQ:STOK)
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Sg Americas Securities , Stoke Therapeutics Inc , Jpmorgan Chase Co , Stoke Therapeutics Company Profile , Mirae Asset Global Investments Co , Securities Exchange Commission , Dorsey Whitney Trust , Canaccord Genuity Group , Needham Company , York Mellon Corp , Stoke Therapeutics , Free Report , Stoke Therapeutic , Genuity Group , Therapeutics Trading Down , Get Free Report , New York Mellon Corp , Asset Global Investments , Whitney Trust , Trexquant Investment , Exchange Commission , Skorpios Trust , Stoke Therapeutics Daily ,

Stoke Therapeutics, Inc. (NASDAQ:STOK) Forecasted to Post FY2028 Earnings of $0.17 Per Share

Stoke Therapeutics, Inc. (NASDAQ:STOK) Forecasted to Post FY2028 Earnings of $0.17 Per Share
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Stephenj Tulipano , Stoke Therapeutics Inc , Stoke Therapeutics Company Profile , Jpmorgan Chase Co , Cantor Fitzgerald , Needham Company , Canaccord Genuity Group , Capital Partners , Mirae Asset Global Investments Co , Securities Exchange Commission , Stoke Therapeutics , Free Report , Stoke Therapeutic , Get Free Report , Therapeutics Stock Down , Exchange Commission , Skorpios Trust , Asset Global Investments , Trexquant Investment , Stoke Therapeutics Daily ,

Wall Street Breakfast Podcast: Lucid Secures $1B Investment

Wall Street Breakfast Podcast: Lucid Secures $1B Investment
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Saudi Arabia , United States , Baker Hughes , Shantanu Narayen , Ed Bastian , Le Peuch , Olivier Le Peuch , Adam Neumann , Adam Jonas , Mary Barra , Dan Loeb , Lucid Group Inc , Ayar Third Investment Company , Morgan Stanley , Lucid Group , Callon Petroleum , United Parcel Service , Apple Podcasts , Third Investment Company , Analyst Adam Jonas , Financial Times , Soviet Union , Wall Street Journal , Third Point , Seeking Alpha , Ford Motor ,

Stoke Therapeutics (NASDAQ:STOK) Given New $14.00 Price Target at Cantor Fitzgerald

Stoke Therapeutics (NASDAQ:STOK) Given New $14.00 Price Target at Cantor Fitzgerald
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong Kong , United States , Barry Ticho , Jonathan Allan , Cantor Fitzgerald , Canaccord Genuity Group , Needham Company , Hong Kong Ltd , Ensign Peak Advisors Inc , Stoke Therapeutics Inc , Great West Life Assurance Co , Credit Suisse Group , Stoke Therapeutics , Free Report , Stoke Therapeutic , Genuity Group , Suisse Group , Moderate Buy , Therapeutics Trading Down , Get Free Report , General Counsel Jonathan Allan , Peak Advisors Inc , Kong Ltd , West Life Assurance , Quantbot Technologies , Stoke Therapeutics Daily ,

Stoke Therapeutics (NASDAQ:STOK) Price Target Lowered to $14.00 at Cantor Fitzgerald

Stoke Therapeutics (NASDAQ:STOK – Free Report) had its target price decreased by Cantor Fitzgerald from $18.00 to $14.00 in a research note released on Tuesday morning, Marketbeat.com reports. Cantor Fitzgerald currently has an overweight rating on the stock. Cantor Fitzgerald also issued estimates for Stoke Therapeutics’ FY2023 earnings at ($2.42) EPS and FY2024 earnings at […] ....

United States , Barry Ticho , Jonathan Allan , Stoke Therapeutics Inc , Metlife Investment Management , Needham Company , Stoke Therapeutics Company Profile , Canaccord Genuity Group , Cantor Fitzgerald , Securities Exchange Commission , York Mellon Corp , Jpmorgan Chase Co , Swiss National Bank , Stoke Therapeutics , Free Report , Stoke Therapeutic , Genuity Group , Moderate Buy , Get Free Report , General Counsel Jonathan Allan , Exchange Commission , National Bank , New York Mellon Corp , Life Investment Management , Rhumbline Advisers , Stoke Therapeutics Daily ,